HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel ...

Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

CNS Pharmaceuticals (CNSP) announced a 1-for-50 reverse split of its common stock. Beginning on February 21, 2025, the Company’s common stock will continue to trade on The Nasdaq Capital Market ...

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments ...

Embryology is the discipline concerned with the study of embryogenesis, the development of the embryo from a fertilised egg cell. Findings in embryology have helped in the understanding of ...

The College of Natural Sciences Common Scholarship Application for current and continuing CNS students is now available through the Longhorn Awards & Student Scholarship Opportunities (LASSO) portal.

As someone who’s completely obsessed with “From,” I’ve been eagerly waiting for any news about season 4. The show’s mind-bending mysteries and constant twists make it my favorite dark ...

A 113-year-old Scarsdale taxi service may be forced to shut down its operations due to impacts of COVID-19 and changes in the taxi businesses. News 12 Photojournalist John Dulak went on a ride ...

Mar. 17, 2025 — The James Webb Space Telescope has captured its first direct images of carbon dioxide in a planet outside the solar system in HR 8799, a multiplanet system 130 light-years away ...

Part 1 of this 2-part article, "Understanding the Embryology and Genetics of Cleft Lip and Palate," presented the embryology of the face, lip, and palate to help the clinician understand the ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma M&A announcement today. The $132-per-share agreement comes a few ...